Quest Diagnostics Current Ratio 2010-2024 | DGX

Current and historical current ratio for Quest Diagnostics (DGX) from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Quest Diagnostics current ratio for the three months ending March 31, 2024 was 0.97.
Quest Diagnostics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2024-03-31 $2.23B $2.30B 0.97
2023-12-31 $2.37B $1.82B 1.31
2023-09-30 $1.82B $1.62B 1.12
2023-06-30 $1.73B $1.88B 0.92
2023-03-31 $1.81B $1.36B 1.34
2022-12-31 $1.90B $1.55B 1.22
2022-09-30 $2.33B $1.60B 1.46
2022-06-30 $2.43B $1.58B 1.54
2022-03-31 $2.48B $1.70B 1.46
2021-12-31 $2.74B $1.75B 1.56
2021-09-30 $2.85B $1.76B 1.62
2021-06-30 $2.15B $1.55B 1.38
2021-03-31 $3.00B $1.71B 1.76
2020-12-31 $3.06B $1.78B 1.72
2020-09-30 $3.35B $2.39B 1.40
2020-06-30 $2.38B $1.84B 1.29
2020-03-31 $1.56B $1.13B 1.38
2019-12-31 $2.49B $1.99B 1.25
2019-09-30 $1.78B $2.01B 0.89
2019-06-30 $1.57B $1.90B 0.82
2019-03-31 $1.78B $2.28B 0.78
2018-12-31 $1.39B $1.49B 0.94
2018-09-30 $1.60B $1.39B 1.15
2018-06-30 $1.42B $1.26B 1.12
2018-03-31 $1.37B $1.12B 1.23
2017-12-31 $1.31B $1.06B 1.24
2017-09-30 $1.54B $1.05B 1.47
2017-06-30 $1.50B $0.92B 1.64
2017-03-31 $1.56B $0.99B 1.58
2016-12-31 $1.53B $0.98B 1.56
2016-09-30 $1.64B $1.05B 1.57
2016-06-30 $1.51B $1.11B 1.36
2016-03-31 $1.49B $1.09B 1.37
2015-12-31 $1.50B $1.17B 1.28
2015-09-30 $1.65B $1.13B 1.46
2015-06-30 $1.53B $1.24B 1.23
2015-03-31 $2.38B $2.09B 1.14
2014-12-31 $1.60B $1.71B 0.94
2014-09-30 $1.56B $1.19B 1.31
2014-06-30 $1.51B $1.26B 1.20
2014-03-31 $1.49B $1.19B 1.25
2013-12-31 $1.38B $1.13B 1.22
2013-09-30 $1.43B $1.24B 1.15
2013-06-30 $1.47B $1.29B 1.14
2013-03-31 $1.46B $1.21B 1.21
2012-12-31 $1.56B $1.05B 1.49
2012-09-30 $1.47B $1.07B 1.38
2012-06-30 $1.48B $1.33B 1.12
2012-03-31 $1.52B $1.53B 1.00
2011-12-31 $1.40B $1.56B 0.90
2011-09-30 $1.40B $1.76B 0.79
2011-06-30 $1.48B $1.99B 0.74
2011-03-31 $2.30B $1.77B 1.30
2010-12-31 $1.61B $1.21B 1.32
2010-09-30 $1.55B $1.15B 1.35
2010-06-30 $1.63B $1.00B 1.64
2010-03-31 $1.65B $1.08B 1.53
2009-12-31 $1.68B $1.06B 1.59
2009-09-30 $1.47B $0.99B 1.48
2009-06-30 $1.34B $1.02B 1.31
2009-03-31 $1.49B $1.27B 1.17
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $15.353B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.002B 10.28
DaVita (DVA) United States $12.299B 15.28
Elanco Animal Health (ELAN) United States $8.994B 23.33
Encompass Health (EHC) United States $8.506B 21.77
Chemed (CHE) United States $8.076B 25.03
Option Care Health (OPCH) United States $4.839B 18.32
RadNet (RDNT) United States $4.232B 88.12
Amedisys (AMED) United States $2.993B 21.20
Astrana Health (ASTH) United States $2.272B 30.72
LifeStance Health (LFST) United States $2.018B 0.00
Addus HomeCare (ADUS) United States $1.914B 27.38
U.S Physical Therapy (USPH) United States $1.400B 37.46
Pennant (PNTG) United States $0.662B 34.98
Aveanna Healthcare Holdings (AVAH) United States $0.491B 0.00
Atai Life Sciences (ATAI) Germany $0.223B 0.00
Daxor (DXR) United States $0.042B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Novo Integrated Sciences (NVOS) United States $0.014B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Ontrak (OTRK) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00